GABAPENTIN
- Product NDC
- 64380-868
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Strides Pharma Science Limited
- Application
- ANDA211314
- Marketing category
- ANDA
- Substance
- GABAPENTIN
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 64380-868-06 | 100 CAPSULE in 1 BOTTLE (64380-868-06) | 20181017 | | No | Historical |
Related DailyMed Labels
| Set ID | Title | Manufacturer | Effective date | Type | Version |
|---|
| 43b67ae3-ac6f-48f5-8788-9ead08376864 | These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993 | Strides Pharma Science Limited | Strides Pharma Global Pte. Ltd. | 2026-05-20 | HUMAN PRESCRIPTION DRUG LABEL | 10 |
| 4c22c3e6-2471-4b89-945b-f846c4d7884e | These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993 | Bryant Ranch Prepack | 2026-03-30 | HUMAN PRESCRIPTION DRUG LABEL | 1 |